Fibrogen FG-3246 Phase 1 Study Results in Metastatic Prostate Cancer
FibroGen announced positive results from a Phase 1 study of FG-3246, an antibody-drug conjugate targeting CD46, in patients with...
Anthos Therapeutics Shares New Data from Landmark AZALEA-TIMI 71 Study
Anthos Therapeutics presented new analyses from the AZALEA-TIMI 71 study at the American College of Cardiology Annual Scientific Session....
Bentracimab Reverses Ticagrelor Effects in Phase 3 Trial
SFJ Pharmaceuticals and SERB Pharmaceuticals announced positive final results from the Phase 3 REVERSE-IT trial of bentracimab, a ticagrelor...
Ninerafaxstat Improves Cardiometabolic HFpEF in Phase 2 Trial
Imbria Pharmaceuticals announced positive Phase 2 trial results for ninerafaxstat in patients with cardiometabolic heart failure with preserved ejection...
Aavant-Garde & TIGEM’s Groundbreaking Research in Science Advances
AAVantgarde Bio, in collaboration with the Telethon Institute of Genetics and Medicine (TIGEM), published preclinical research in Science Advances...
Vaxcyte Announces Positive VAX-24 Infant Phase 2 Results
Vaxcyte, a clinical-stage vaccine company, will present topline results from its Phase 2 infant study of VAX-24, a 24-valent...
Understanding the FDA’s Draft Guidance on Protocol Deviations in Clinical Investigations
The U.S. Food and Drug Administration (FDA) has released a draft guidance document titled Protocol Deviations for Clinical Investigations of...
PathAI: Clinical Trial Pathology Revolution
In this interview, we engage with PathAI leaders: Eric Walk, MD, Chief Medical Officer; Ella Stewart, Senior Product Manager;...
Promising Early Data from NBTXR3 Phase 1 Study in Advanced NSCLC
Nanobiotix announced positive Phase 1 data for NBTXR3 (JNJ-1900), a radiotherapy-activated nanoparticle therapy, in patients with locally advanced non-small...
Promising Portage Biotech Preclinical Results Support Trial
Portage Biotech presented preclinical data for PORT-7 (TT-4), a selective A2B adenosine receptor inhibitor, at the 2025 European Lung...